Evidence map›Paper›PMID 21606539›Full record

ArticleThe Journal of infectious diseases2011

The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Mark H Kuniholm, Xiaojiang Gao, Xiaonan Xue, Andrea Kovacs, Darlene Marti, Chloe L Thio, Marion G Peters, Ruth M Greenblatt, James J Goedert, Mardge H Cohen and 7 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

Mark H KuniholmDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. mark.kuniholm@einstein.yu.edu
Xiaojiang Gao
Xiaonan Xue
Andrea Kovacs
Darlene Marti
Chloe L Thio
Marion G Peters
Ruth M Greenblatt
James J Goedert
Mardge H Cohen
Howard Minkoff
Stephen J Gange
Kathryn Anastos
Melissa Fazzari
Mary A Young
Howard D Strickler
Mary Carrington
Albert Einstein College of Medicine · USScience Applications International Corporation (United States) · USCook County Health and Hospitals System · USGeorgetown University · USJohns Hopkins University · USMaimonides Medical Center · USNational Institutes of Health · USRagon Institute of MGH, MIT and Harvard · USUniversity of California, San Francisco · USUniversity of Southern California · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
HCV and Progression of HIV and HAART Response in WomenR01AI052065 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KOVACS, ANDREA A.Z. · 2002 to 2011
$6.9M
Microbes and Human MalignanciesZIACP010214 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI VOGTMANN, EMILY · 2010 to 2021
$5.5M
HIV AND HCV DISEASE PROGRESSION IN WOMEN ON HAARTR56AI052065 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KOVACS, ANDREA A.Z. · 2014 to 2014
$655k
NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI052065NIAID NIH HHS R56 AI052065
6 · The paper itself

Abstract

backgroundHuman leukocyte antigen (HLA) class I and II genotype is associated with clearance of hepatitis C virus (HCV) infection, but little is known regarding its relation with HCV viral load or risk of liver disease in patients with persistent HCV infection.

methodsHigh-resolution HLA class I and II genotyping was conducted in a prospective cohort of 519 human immunodeficiency virus (HIV)-seropositive and 100 HIV-seronegative women with persistent HCV infection. The end points were baseline HCV viral load and 2 noninvasive indexes of liver disease, fibrosis-4 (FIB-4), and the aspartate aminotransferase to platelet ratio index (APRI), measured at baseline and prospectively.

resultsDQB1*0301 was associated with low baseline HCV load (β = -.4; 95% confidence interval [CI], -.6 to -.3; P < .00001), as well as with low odds of FIB-4-defined (odds ratio [OR], .5; 95% CI, .2-.9; P = .02) and APRI-defined liver fibrosis (OR, .5; 95% CI, .3-1.0; P = .06) at baseline and/or during follow-up. Most additional associations with HCV viral load also involved HLA class II alleles. Additional associations with FIB-4 and APRI primarily involved class I alleles, for example, the relation of B*1503 with APRI-defined fibrosis had an OR of 2.0 (95% CI, 1.0-3.7; P = .04).

conclusionsHLA genotype may influence HCV viral load and risk of liver disease, including DQB1*0301, which was associated with HCV clearance in prior studies.

Indexed as

AdultAlanine TransaminaseAllelesAspartate AminotransferasesCohort StudiesFemaleGenotypeHepacivirusHepatitis C, ChronicHIV InfectionsHLA AntigensHLA-DQ AntigensHumansLiver CirrhosisLogistic ModelsPlatelet CountAlanine TransaminaseAspartate AminotransferasesHLA AntigensHLA-DQ Antigens

Identifiers

PMID21606539
PMCPMC3100515
OpenAlexW2105817464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.